Citations

Citations to this article as recorded by  

• Sulforaphane reduces adipose tissue fibrosis via promoting M2 macrophages polarization in HFD fed-mice
  Zhenzhen Zhang, Huali Chen, Cheng Pan, Rui Li, Wangsheng Zhao, Tianzeng Song
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119626.     CrossRef
• Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms
  Patrícia dos Santos Azeredo, Daping Fan, E. Angela Murphy, Wayne E. Carver
  Cells.2024; 13(5): 421.     CrossRef
• Beneficial role of broccoli and its active ingredient, sulforaphane in the treatment of diabetes
  Aminu Mohammed, Hafsat Abdullahi Mohammed
  Phytomedicine Plus.2023; 3(2): 100431.     CrossRef
• The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
  Christodoula Kourtidou, Konstantinos Tziomalos
  International Journal of Molecular Sciences.2023; 24(6): 6007.     CrossRef
• Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
  Da-Wei Lin, Yung-Chien Hsu, Cheng-Chih Chang, Ching-Chuan Hsieh, Chun-Liang Lin
  International Journal of Molecular Sciences.2023; 24(7): 6053.     CrossRef
• Beneficial Effects of Sulforaphane on Diabetes and Its Complications via Both Nrf2-Dependent and Independent Mechanisms
  Minhyuk Kim, Joo Young Lee
  Food Supplements and Biomaterials for Health.2023;[Epub]     CrossRef
• Sulforaphane exhibits potent renoprotective effects in preclinical models of kidney diseases: A systematic review and meta-analysis
  Elisa B. Monteiro, Matheus Ajackson, Milena B. Stockler-Pinto, Fitsum Guebre-Egziabher, Julio B. Daleprane, Christophe O. Soulage
  Life Sciences.2023; 322: 121664.     CrossRef
• Integrated single-cell RNA-seq analysis revealed podocyte injury through activation of the BMP7/AMPK/mTOR mediated autophagy pathway
  Hongzhou Lin, Huihui Chen, Rengcheng Qian, Guoqi Tang, Yinjuan Ding, Yalan Jiang, Congde Chen, Dexuan Wang, Maoping Chu, Xiaoling Guo
  Chemico-Biological Interactions.2023; 382: 110559.     CrossRef
• Underlying mechanisms and molecular targets of genistein in the management of type 2 diabetes mellitus and related complications
  Tao Jiang, Yuhe Dong, Wanying Zhu, Tong Wu, Linyan Chen, Yuantong Cao, Xi Yu, Ye Peng, Ling Wang, Ying Xiao, Tian Zhong
  Critical Reviews in Food Science and Nutrition.2023; : 1.     CrossRef
• Sulforaphane: A nutraceutical against diabetes-related complications
  Sinenhlanhla X.H. Mthembu, Sithandiwe E. Mazibuko-Mbeje, Marakiya T. Moetlediwa, Ndivhuwo Muvhulawa, Sonia Silvestri, Patrick Orlando, Bongani B. Nkambule, Christo J.F. Muller, Duduzile Ndwandwe, Albertus K. Basson, Luca Tiano, Phiwayinkosi V. Dludla
  Pharmacological Research.2023; 196: 106918.     CrossRef
• Nrf2/HO-1 as a therapeutic target in renal fibrosis
  Emad H.M. Hassanein, Islam M. Ibrahim, Esraa K. Abd-alhameed, Zeina W. Sharawi, Fatima A. Jaber, Hanan S. Althagafy
  Life Sciences.2023; 334: 122209.     CrossRef
• A mechanistic overview of sulforaphane and its derivatives application in diabetes and its complications
  Neda Mohamadi, Vafa Baradaran Rahimi, Mohammad Reza Fadaei, Fatemeh Sharifi, Vahid Reza Askari
  Inflammopharmacology.2023; 31(6): 2885.     CrossRef
• The HDAC2/SP1/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease
  Zongji Zheng, Shuting Zhang, Jiaqi Chen, Meina Zou, Yanlin Yang, Wen Lu, Shijing Ren, Xiangyu Wang, Wenhui Dong, Zikun Zhang, Ling Wang, Meiping Guan, Gladys L.Y. Cheing, Yaoming Xue, Yijie Jia
  Clinical Science.2022; 136(3): 223.     CrossRef
• BMP-7 Upregulates Id2 Through the MAPK Signaling Pathway to Improve Diabetic Tubulointerstitial Fibrosis and the Intervention of Oxymatrine
  Yawen Xiao, Dan Liang, Zhiyang Li, Zhaowei Feng, Zhiping Yuan, Fan Zhang, Yuanyuan Wang, Yuxia Zhou, Mingjun Shi, Lingling Liu, Ying Xiao, Bing Guo
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• HDAC1 Promotes Myocardial Fibrosis in Diabetic Cardiomyopathy by Inhibiting BMP-7 Transcription Through Histone Deacetylation
  Chun Ouyang, Lei Huang, Xiaoqiang Ye, Mingming Ren, Zhen Han
  Experimental and Clinical Endocrinology & Diabetes.2022; 130(10): 660.     CrossRef
• Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation
  Jialu Li, Chao Yu, Fengchen Shen, Binbin Cui, Na Liu, Shougang Zhuang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
  Jiayu Wang, Jiaxing Li, Xin Zhang, Min Zhang, Xiaopeng Hu, Hang Yin
  Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
• The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review
  Mengjiao Wang, Min Chen, Rui Guo, Yangyang Ding, Haihui Zhang, Yuanqing He
  Trends in Food Science & Technology.2022; 129: 397.     CrossRef
• Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
  Hao Yan, Jiangxin Xu, Zhifei Xu, Bo Yang, Peihua Luo, Qiaojun He
  Biomedicine & Pharmacotherapy.2021; 143: 112115.     CrossRef